Tenea, G.N.; Molina, D.; Cuamacas, Y.; Marinescu, G.C.; Popescu, R.G.
Exometabolite-Based Antimicrobial Formulations from Lactic Acid Bacteria as a Multi-Target Strategy Against Multidrug-Resistant Escherichia coli. Antibiotics 2025, 14, 851.
https://doi.org/10.3390/antibiotics14090851
AMA Style
Tenea GN, Molina D, Cuamacas Y, Marinescu GC, Popescu RG.
Exometabolite-Based Antimicrobial Formulations from Lactic Acid Bacteria as a Multi-Target Strategy Against Multidrug-Resistant Escherichia coli. Antibiotics. 2025; 14(9):851.
https://doi.org/10.3390/antibiotics14090851
Chicago/Turabian Style
Tenea, Gabriela N., Diana Molina, Yuleissy Cuamacas, George Cătălin Marinescu, and Roua Gabriela Popescu.
2025. "Exometabolite-Based Antimicrobial Formulations from Lactic Acid Bacteria as a Multi-Target Strategy Against Multidrug-Resistant Escherichia coli" Antibiotics 14, no. 9: 851.
https://doi.org/10.3390/antibiotics14090851
APA Style
Tenea, G. N., Molina, D., Cuamacas, Y., Marinescu, G. C., & Popescu, R. G.
(2025). Exometabolite-Based Antimicrobial Formulations from Lactic Acid Bacteria as a Multi-Target Strategy Against Multidrug-Resistant Escherichia coli. Antibiotics, 14(9), 851.
https://doi.org/10.3390/antibiotics14090851